Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $544.2300 (-1.32%) ($542.1500 - $552.0300) on Fri. Dec. 18, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.4% (three month average) | | RSI | 51 | | Latest Price | $544.2300(-1.32%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | | Weekly Trend | REGN advances 0.4% a week on average for past two weeks. | | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(64%) XLV(51%) XBI(49%) QQQ(42%) IVW(41%) | | Factors Impacting REGN price | REGN will decline at least -1.2% in a week (0% probabilities).
VIXM(-13%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-3%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.2% (StdDev 2.4%) | | Hourly BBV | 0 () | | Intraday Trend | -0.7% | | | | | |
|
| Resistance Level | $552.55 | | 5 Day Moving Average | $550.36(-1.11%) | | 10 Day Moving Average | $548.52(-0.78%) | | 20 Day Moving Average | $552.55(-1.51%) | | To recent high | -7.3% | | To recent low | 20.5% | | Market Cap | $57.704b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |